Knight Therapeutics Inc. (TSX: GUD)
Canada
· Delayed Price · Currency is CAD
5.98
-0.06 (-0.99%)
Sep 11, 2024, 2:58 PM EDT
Knight Therapeutics Employees
Knight Therapeutics had 725 employees as of December 31, 2023. The number of employees increased by 27 or 3.87% compared to the previous year.
Employees
725
Change (1Y)
27
Growth (1Y)
3.87%
Revenue / Employee
466.03K CAD
Profits / Employee
-29.28K CAD
Market Cap
611.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bausch + Lomb Corporation | 13,300 |
Bausch Health Companies Inc. | 20,270 |
Curaleaf Holdings, Inc. | 5,650 |
Tilray Brands, Inc. | 2,650 |
dentalcorp Holdings Ltd. | 9,900 |
Sienna Senior Living Inc. | 12,263 |
Cronos Group Inc. | 356 |
WELL Health Technologies Corp. | 1,507 |
Knight Therapeutics News
- 4 weeks ago - Knight Therapeutics Reports Second Quarter 2024 - GlobeNewsWire
- 5 weeks ago - Notice of Knight Therapeutics’ Second Quarter 2024 Results Conference Call - Financial Post
- 5 weeks ago - Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call - GlobeNewsWire
- 4 months ago - Knight Therapeutics, Inc. (KHTRF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Knight Therapeutics reports Q1 results - Seeking Alpha
- 4 months ago - Knight Therapeutics Reports First Quarter 2024 Results - GlobeNewsWire
- 4 months ago - Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America - GlobeNewsWire
- 4 months ago - Knight Therapeutics Inc. announces voting results from the Annual General Meeting - GlobeNewsWire